Fasching PA - Search Results

1

Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany".

Schneeweiss A, Ettl J, Lüftner D, Beckmann MW, Belleville E, Fasching PA, Fehm TN, Geberth M, Häberle L, Hadji P, Hartkopf AD, Hielscher C, Huober J, Ruckhäberle E, Janni W, Kolberg HC, Kurbacher CM, Klein E, Lux MP, Müller V, Nabieva N, Overkamp F, Tesch H, Laakmann E, Taran FA, Seitz J, Thomssen C, Untch M, Wimberger P, Wuerstlein R, Volz B, Wallwiener D, Wallwiener M, Brucker SY. Schneeweiss A, et al. Among authors: fasching pa. Breast. 2021 Feb;55:138-139. doi: 10.1016/j.breast.2020.12.007. Epub 2021 Jan 5. Breast. 2021. PMID: 33413981 Free PMC article. No abstract available.

2

Aspects of molecular diagnostics and therapy in obstetrics and gynecology.

Beckmann MW, Strick R, Strissel PL, Fasching PA, Oppelt P, Pöhls UD, Malur SU, Ackermann S. Beckmann MW, et al. Among authors: fasching pa. Expert Rev Mol Diagn. 2003 May;3(3):279-87. doi: 10.1586/14737159.3.3.279. Expert Rev Mol Diagn. 2003. PMID: 12779004 Review.

3

Hereditary breast and ovarian cancer: review and future perspectives.

Lux MP, Fasching PA, Beckmann MW. Lux MP, et al. Among authors: fasching pa. J Mol Med (Berl). 2006 Jan;84(1):16-28. doi: 10.1007/s00109-005-0696-7. Epub 2005 Nov 11. J Mol Med (Berl). 2006. PMID: 16283147 Review.

4

Age of uptake of early cancer detection facilities by low-risk and high-risk patients with familial breast and ovarian cancer.

Lux MP, Ackermann S, Bani MR, Nestle-Krämling C, Goecke TO, Niederacher D, Bodden-Heidrich R, Bender HG, Beckmann MW, Fasching PA. Lux MP, et al. Among authors: fasching pa. Eur J Cancer Prev. 2005 Dec;14(6):503-11. doi: 10.1097/00008469-200512000-00003. Eur J Cancer Prev. 2005. PMID: 16284494

5

Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics.

Fasching PA, Heusinger K, Loehberg CR, Wenkel E, Lux MP, Schrauder M, Koscheck T, Bautz W, Schulz-Wendtland R, Beckmann MW, Bani MR. Fasching PA, et al. Eur J Radiol. 2006 Dec;60(3):398-404. doi: 10.1016/j.ejrad.2006.08.002. Epub 2006 Oct 9. Eur J Radiol. 2006. PMID: 17030108

6

The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs.

Fasching PA, von Minckwitz G, Fischer T, Kaufmann M, Schultz-Zehden B, Beck H, Lux MP, Jacobs V, Meden H, Kiechle M, Beckmann MW, Paepke S. Fasching PA, et al. Breast Cancer Res Treat. 2007 Jan;101(1):95-104. doi: 10.1007/s10549-006-9272-2. Epub 2006 Oct 11. Breast Cancer Res Treat. 2007. PMID: 17033928

7

Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers.

Ackermann S, Lux MP, Fasching PA, Strissl P, Renner SP, Poehls U, Bender HG, Beckmann MW. Ackermann S, et al. Among authors: fasching pa. Eur J Cancer Prev. 2006 Dec;15(6):474-9. doi: 10.1097/01.cej.0000220628.62610.ea. Eur J Cancer Prev. 2006. PMID: 17106324

8

Hormones and genetics caught in the crossfire of preventive medicine.

Fasching PA, Beckmann MW. Fasching PA, et al. Lancet Oncol. 2007 Jan;8(1):5-6. doi: 10.1016/S1470-2045(06)70987-1. Lancet Oncol. 2007. PMID: 17196506 No abstract available.

9

Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit.

Bani HA, Fasching PA, Lux MM, Rauh C, Willner M, Eder I, Loehberg C, Schrauder M, Beckmann MW, Bani MR. Bani HA, et al. Among authors: fasching pa. Patient Educ Couns. 2007 Jun;66(3):311-8. doi: 10.1016/j.pec.2007.01.004. Epub 2007 Feb 27. Patient Educ Couns. 2007. PMID: 17331692

10

Evaluation of mathematical models for breast cancer risk assessment in routine clinical use.

Fasching PA, Bani MR, Nestle-Krämling C, Goecke TO, Niederacher D, Beckmann MW, Lux MP. Fasching PA, et al. Eur J Cancer Prev. 2007 Jun;16(3):216-24. doi: 10.1097/CEJ.0b013e32801023b3. Eur J Cancer Prev. 2007. PMID: 17415092

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

845 results

Search Page

Filters